Up-regulation of ERCC1 expression was found in all 10 ovarian cancer samples exposed to topotecan (p < 0.002, Wilcoxon), and in all 7 colorectal specimens treated with irinotecan, although in this group the increase was modest (p = 0.016, Wilcoxon). The gene discussed is ERCC1; the disease is ovarian carcinoma.